CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

Abroad (travel likely)RecruitingPHASE2

Conditions

Multiple Myeloma (MM) · Multiple Myeloma Light Chain Induced Renal Insufficiency

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin, China
Contact: Study coordinator (Gang An, PhD & MD) · angang@ihcams.ac.cn · 0086 13502181109

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2

Edmonton, Canada · St. John's, Canada

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

Multiple Myeloma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Duarte, United States · Irvine, United States

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

Multiple Myeloma · Plasma Cell Leukemia

Abroad (travel likely)RecruitingPHASE2

Salt Lake City, United States

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Leukemia, Myeloid, Acute · Leukemia, Lymphocytic, Acute · Multiple Myeloma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Newport Beach, United States · Palo Alto, United States